Teva Announces Launch of Generic Protonix(R) Tablets, 20 mg and 40 mg (Finanzen.net)
Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced today that it has commercially launched Pantoprazole Sodium Delayed Release (DR) Tablets, 20 mg and 40 mg, which are AB-rated to Wyeth's erosive GERD treatment Protonix ...

Teva Announces Launch of Generic Protonix(R) Tablets, 20 mg and 40 mg (Business Wire via Yahoo! Finance)
JERUSALEM----Teva Pharmaceutical Industries Ltd. announced today that it has commercially launched Pantoprazole Sodium Delayed Release Tablets, 20 mg and 40 mg, which are AB-rated to Wyeth's erosive GERD treatment Protonix DR Tablets.

Abiomed Receives FDA Approval For The Combination IPulse Circulatory Support System (Medical News Today)
Abiomed, Inc. (NASDAQ: ABMD) announced that it has received approval from the U.S. Food and Drug Administration (FDA) for U.S. commercial distribution of the Company's combination iPulse Circulatory Support System. [click link for full article]